1Li ZQ,Cheng TO,Zhang WW,et al.Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy.The Chinese experience in 119 patients from a single center.Int J Cardiol,2004,93:197-202.
2Faber L,Seggewiss H,Gleichmann U.Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy:results with respect to intraprocedural myocardial contrast echocardiography.Circulation,1998,98:2415-2421.
3Blanchard DG,Ross J Jr.Hypertrophic cardiomyopathy:prognosis with medical or surgical therapy.Clin Cardiol,1991,14:11-19.
4Fananapazir L,McAreavey D.Therapeutic options in patients with obstructive hypertrophic cardiomyopathy and severe drug-refractory symptoms.J Am Coll Cardiol,1998,31:259-264.
5Spirito P,Maron BJ.Perspectives on the role of new treatment strategies in hypertrophic obstructive cardiomyopathy.J Am Coll Cardiol,1999,33:1071-1075.
6Maron BJ,Nishimura RA,McKenna WJ,et al.Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy.A randomized,double-blind,crossover study (M-PATHY).Circulation,1999,99:2927-2933.
7Sigwart U.Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy.Lancet,1995,346:211-214.
8Kern MJ,Holmes DG,Simpson C,et al.Delayed occurrence of complete heart block without warning after alcohol septal ablation for hypertrophic obstructive cardiomyopathy.Catheter Cardiovasc Interv,2002,56:503-507.
9Nagano S,Miyahara K,Sohara H,et al.Angina pectoris or myocardial infarction? Pure septal infarction.J Cardiol,2002,39:277-280.
